Teresa Ramirez-Montagut, Ph.D. - Publications

Affiliations: 
2003 Weill Cornell Medical College, New York, NY, United States 
Area:
Immunology, Molecular Biology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Blachère NE, Orange DE, Gantman EC, Santomasso BD, Couture GC, Ramirez-Montagut T, Fak J, O'Donovan KJ, Ru Z, Parveen S, Frank MO, Moore MJ, Darnell RB. T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy. Jci Insight. 2. PMID 29093272 DOI: 10.1172/jci.insight.96173  0.536
2011 Dubrovska A, Kim C, Elliott J, Shen W, Kuo TH, Koo DI, Li C, Tuntland T, Chang J, Groessl T, Wu X, Gorney V, Ramirez-Montagut T, Spiegel DA, Cho CY, et al. A chemically induced vaccine strategy for prostate cancer. Acs Chemical Biology. 6: 1223-31. PMID 21936526 DOI: 10.1021/Cb200222S  0.315
2011 Gauba V, Grünewald J, Gorney V, Deaton LM, Kang M, Bursulaya B, Ou W, Lerner RA, Schmedt C, Geierstanger BH, Schultz PG, Ramirez-Montagut T. Loss of CD4 T-cell-dependent tolerance to proteins with modified amino acids. Proceedings of the National Academy of Sciences of the United States of America. 108: 12821-6. PMID 21768354 DOI: 10.1073/Pnas.1110042108  0.411
2007 Ramirez-Montagut T, Chow A, Kochman AA, Smith OM, Suh D, Sindhi H, Lu S, Borsotti C, Grubin J, Patel N, Terwey TH, Kim TD, Heller G, Murphy GF, Liu C, et al. IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 179: 1669-80. PMID 17641033 DOI: 10.4049/Jimmunol.179.3.1669  0.58
2006 Ferrone CR, Perales MA, Goldberg SM, Somberg CJ, Hirschhorn-Cymerman D, Gregor PD, Turk MJ, Ramirez-Montagut T, Gold JS, Houghton AN, Wolchok JD. Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 5511-9. PMID 17000687 DOI: 10.1158/1078-0432.Ccr-06-0979  0.468
2006 Ramirez-Montagut T, Chow A, Hirschhorn-Cymerman D, Terwey TH, Kochman AA, Lu S, Miles RC, Sakaguchi S, Houghton AN, van den Brink MR. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 176: 6434-42. PMID 16709800 DOI: 10.4049/Jimmunol.176.11.6434  0.625
2005 Terwey TH, Kim TD, Kochman AA, Hubbard VM, Lu S, Zakrzewski JL, Ramirez-Montagut T, Eng JM, Muriglan SJ, Heller G, Murphy GF, Liu C, Budak-Alpdogan T, Alpdogan O, van den Brink MR. CCR2 is required for CD8-induced graft-versus-host disease. Blood. 106: 3322-30. PMID 16037386 DOI: 10.1182/Blood-2005-05-1860  0.572
2005 Hubbard VM, Eng JM, Ramirez-Montagut T, Tjoe KH, Muriglan SJ, Kochman AA, Terwey TH, Willis LM, Schiro R, Heller G, Murphy GF, Liu C, Alpdogan O, van den Brink MR. Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation. Blood. 106: 3285-92. PMID 15956289 DOI: 10.1182/Blood-2005-01-0410  0.51
2005 Ramirez-Montagut T, Chow A, Kochman AA, Hubbard VM, Suh D, Smith OM, Sindhi H, Terwey TH, Kim TD, Waldman E, Alpdogan O, van den Brink MR. Graft-Versus-Tumor Activity Against Renal Cell Carcinoma in a Mouse Model of HSCT. Blood. 106: 1317-1317. DOI: 10.1182/Blood.V106.11.1317.1317  0.58
2004 Muriglan SJ, Ramirez-Montagut T, Alpdogan O, Van Huystee TW, Eng JM, Hubbard VM, Kochman AA, Tjoe KH, Riccardi C, Pandolfi PP, Sakaguchi S, Houghton AN, Van Den Brink MR. GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease. The Journal of Experimental Medicine. 200: 149-57. PMID 15249593 DOI: 10.1084/Jem.20040116  0.592
2004 Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P, Houghton AN. FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene. 23: 5435-46. PMID 15133496 DOI: 10.1038/Sj.Onc.1207730  0.538
2004 Hubbard VM, Eng JM, Tjoe KH, Ramirez-Montagut T, Muriglan SJ, Kochman AA, Terwey TH, Schiro R, Alpdogan O, Brink MRMvd. Absence of Inducible Costimulator (ICOS) on Alloreactive T Cells Reduces Graft-versus-Host-Disease While Leaving Graft-Versus-Tumor Activity Intact. Blood. 104: 592-592. DOI: 10.1182/Blood.V104.11.592.592  0.527
2004 Muriglan SJ, Ramirez-Montagut T, Alpdogan O, Huystee Tv, Eng JM, Hubbard VM, Kochman AA, Tjoe KH, Brink MRMvD. The paradoxical effect of glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) activation on alloreactive CD4 and CD8 T cells and the development of GVHD Biology of Blood and Marrow Transplantation. 10: 5. DOI: 10.1016/J.Bbmt.2003.12.009  0.532
2003 Ramirez-Montagut T, Turk MJ, Wolchok JD, Guevara-Patino JA, Houghton AN. Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity. Oncogene. 22: 3180-7. PMID 12789294 DOI: 10.1038/Sj.Onc.1206462  0.604
Show low-probability matches.